FindTrial
Sign In

Development of individualized anticoagulation method in atrial fibrillation patients with end stage renal disease

Development of individualized anticoagulation method in atrial fibrillation patients with end stage renal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006397
Enrollment
1000
Registered
2021-07-29
Start date
2021-05-31
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Wonju College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: End stage renal disease patients with receiving renal replacement therapy with atrial fibrillation

Exclusion criteria

Exclusion criteria: patients under 18 years old or over 90 years old

Design outcomes

Primary

MeasureTime frame
all cause mortality—

Secondary

MeasureTime frame
major organ bleeding—

Countries

Korea, Republic of

Contacts

Public ContactJUN YOUNG LEE

Yonsei University Wonju College of Medicine

junyoung07@yonsei.ac.kr+82-33-741-0935

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026